LIPOSARCOMA, DEDIFFERENTIATED
Clinical trials for LIPOSARCOMA, DEDIFFERENTIATED explained in plain language.
Never miss a new study
Get alerted when new LIPOSARCOMA, DEDIFFERENTIATED trials appear
Sign up with your email to follow new studies for LIPOSARCOMA, DEDIFFERENTIATED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for rare liposarcoma
Disease control CompletedThis study tested whether adding pioglitazone (a diabetes drug) to trabectedin (a chemotherapy) can help shrink or control liposarcoma, a rare cancer of fat tissue. It included 10 adults whose cancer had stopped growing but not shrunk after at least 4 cycles of trabectedin alone.…
Matched conditions: LIPOSARCOMA, DEDIFFERENTIATED
Phase: PHASE2 • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Disease control
Last updated May 26, 2026 07:33 UTC
-
New pill takes on chemo in rare cancer battle
Disease control CompletedThis study tested a new oral drug, brigimadlin, against standard chemotherapy (doxorubicin) in 400 adults with advanced dedifferentiated liposarcoma, a rare soft-tissue cancer. Participants received either the pill every 3 weeks or chemo infusions, with the option to switch if ch…
Matched conditions: LIPOSARCOMA, DEDIFFERENTIATED
Phase: PHASE2, PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 26, 2026 07:25 UTC
-
New pill shows promise for rare Fat-Cell cancer in phase 3 trial
Disease control CompletedThis study tested a new cancer pill called brigimadlin (BI 907828) in 138 adults with a rare type of fat-cell cancer called dedifferentiated liposarcoma. Participants took the pill once every three weeks. Doctors monitored side effects and checked if tumors shrank. The goal was t…
Matched conditions: LIPOSARCOMA, DEDIFFERENTIATED
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 19, 2026 12:01 UTC